{"id":"CHEMBL1003","canonicalSmiles":"O=C([O-])[C@H]1/C(=C/CO)O[C@@H]2CC(=O)N21.[K+]","inchiKey":"ABVRVIZBZKUTMK-JSYANWSFSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CLAVULANATE POTASSIUM","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL777","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BRL 14151K","BRL-14151K","Clavulanate potassium","Potassium clavulanate"],"crossReferences":{"DailyMed":["clavulanate%20potassium"],"chEBI":["85264"]},"count":10,"approvedIndications":["EFO_0003106","EFO_0003103","EFO_0007486","EFO_0000544","EFO_0004992"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 5 approved and 5 investigational indications."}
{"id":"CHEMBL1044","canonicalSmiles":"O=C(O)Cc1ccccc1","inchiKey":"WLJVXDMOQOGPHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Buphenyl","Phenylacetate"],"crossReferences":{"PubChem":["144206593","144207731","170465102","418014"],"Wikipedia":["Phenylacetic_acid"],"drugbank":["DB09269"],"chEBI":["30745"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL105720","canonicalSmiles":"CSC[S@+]([O-])C[C@H](CO)NC(=O)/C=C/c1c(C)[nH]c(=O)[nH]c1=O","inchiKey":"XKLZIVIOZDNKEQ-CLQLPEFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL105720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04222"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1076257","canonicalSmiles":"Nc1nc(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F","inchiKey":"IDYKCXHJJGMAEV-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1076257","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12957"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1077975","canonicalSmiles":"CC(O)C(=O)O.O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O","inchiKey":"NRBJWZSFNGZBFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIPROFLOXACIN LACTATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL8","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ciprofloxacin Lactate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1084647","canonicalSmiles":"CC(=O)O.OCc1cc([C@@H](O)CNCCCCCCOCCOCc2c(Cl)cccc2Cl)ccc1O","inchiKey":"TVWAEQRFKRTYIG-JIDHJSLPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VILANTEROL ACETATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1198857","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vilanterol"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1090488","canonicalSmiles":"C[C@H]1CN(C(=O)[C@@H]2CN(C(C)(C)C)C[C@H]2c2ccc(F)cc2F)C[C@@H](C)[C@]1(O)c1ccccc1","inchiKey":"WHPJOAUPIZDJNX-AGGGUQDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-00446687","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-PF-00446687","Pf-00446687"],"crossReferences":{"drugbank":["DB12517"]},"childChemblIds":["CHEMBL1204059"],"count":2,"linkedTargets":{"rows":["ENSG00000166603"],"count":1},"linkedDiseases":{"rows":["EFO_0004714","EFO_0004234"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL109341","canonicalSmiles":"COc1cc(/C=C/C(=O)O)cc(OC)c1O","inchiKey":"PCMORTLOPMLEFB-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SINAPINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sinapic Acid"],"crossReferences":{"PubChem":["47193735"],"Wikipedia":["Sinapinic_acid"],"drugbank":["DB08587"],"chEBI":["15714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1096927","canonicalSmiles":"CC(C)=CCC[C@](C)(O)[C@@H]1CC=C(C)CC1","inchiKey":"RGZSQWQPBWRIAQ-CABCVRRESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-Bisabolol","Levomenol"],"crossReferences":{"PubChem":["144211692"],"drugbank":["DB13153"],"chEBI":["125"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL112953","canonicalSmiles":"C#CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2Cl)nc2c(N)nc(F)nc21","inchiKey":"KCIOVTSUEXGUFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL112953","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02550"],"chEBI":["47628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1161253","canonicalSmiles":"N=C(N)c1cccc(C[C@H](NS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CCCC[C@@H]2C(=O)O)c1","inchiKey":"GNANSBQAIRJZPA-XZOQPEGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161253","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04238"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1167","canonicalSmiles":"CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12","inchiKey":"UNFWWIHTNXNPBV-WXKVUWSESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPECTINOMYCIN","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["CHX-3101","Spectinomycin","Trobicin"],"crossReferences":{"PubChem":["26754323"],"Wikipedia":["Spectinomycin"],"drugbank":["DB00919"],"chEBI":["9215"]},"childChemblIds":["CHEMBL1443447","CHEMBL1969020","CHEMBL4543601","CHEMBL3184600","CHEMBL1200407","CHEMBL3989571"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1200370","canonicalSmiles":"O=C(OOC(=O)c1ccccc1)c1ccccc1","inchiKey":"OMPJBNCRMGITSC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZOYL PEROXIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acetoxyl 2.5","Acetoxyl 5","Acne-aid cream","Acnecide","Acnecide 10","Acnegel","Acnegel fte","Acnidazil","Benoxyl","Benoxyl 10","Benoxyl 20","Benoxyl 5","Benzac","Benzac w","Benzagel 10","Benzagel 5","Benzamycin","Brevoxyl","Clear by design","Clearasil max 10","Dermoxyl","Dry and clear","Dry clear","Epi-clear","Fostex bpo bar, gel, and wash","Gppe lotio gel","Loroxide","Mediclear","Mediclear acne 10","Mediclear acne 5","Nericur","Oxy-10","Oxy-10 cover-up","Oxy-5","Panoxyl","Panoxyl 10","Panoxyl 10 acnegel","Panoxyl 10 aquagel","Panoxyl 2.5 aquagel","Panoxyl 5 acnegel","Panoxyl 5 aquagel","Panoxyl crm 5","Panoxyl lot 10","Panoxyl lot 5","Persa-gel","Quinoderm 5","Quinoped","Theraderm 10","Theraderm 5","Topex","Ultra clearasil","Valderma","Vanair","Vanoxide"],"synonyms":["Benzoyl peroxide","E928","NSC-671","NSC-675"],"crossReferences":{"DailyMed":["benzoyl%20peroxide"],"PubChem":["170464986","26754472","29215306"],"Wikipedia":["Benzoyl_peroxide"],"drugbank":["DB09096"],"chEBI":["82405"]},"count":3,"approvedIndications":["EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for acne and has 2 investigational indications."}
{"id":"CHEMBL1200584","canonicalSmiles":"Nc1ccc(C(=O)[O-])c(O)c1.[K+]","inchiKey":"PRZJIMSXCLZGLT-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINOSALICYLATE POTASSIUM","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1169","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paskalium","Potassium aminosalicylate"],"synonyms":["Aminosalicylate potassium","Potassium aminosalicylate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1955."}
{"id":"CHEMBL1200671","canonicalSmiles":"CC(=O)O.CC(C)C[C@H](NC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O","inchiKey":"FUCZIEGYURIPAY-CFWZQLQRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"NAFARELIN ACETATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201309","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Synarel"],"synonyms":["Nafarelin acetate","Nafarelin acetate anhydrous","Nafarelin acetate hydrate","RS-94991","RS-94991-298"],"crossReferences":{"DailyMed":["nafarelin%20acetate"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000545"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1200813","canonicalSmiles":"CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1.Cl","inchiKey":"KTUFKADDDORSSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACEBUTOLOL HYDROCHLORIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL642","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acebut hcl","Acebutolol hydrochloride","Sectral","Sectral 200","Sectral 400"],"synonyms":["Acebutolol hydrochloride","IL-17803A","M&B 17803A","M&B-17803A"],"crossReferences":{"DailyMed":["acebutolol%20hydrochloride"],"PubChem":["144204184","170465309","56424136","855517"],"chEBI":["2380"]},"count":2,"approvedIndications":["HP_0004308","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["HP_0004308","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for hypertension and ventricular arrhythmia."}
{"id":"CHEMBL1200822","canonicalSmiles":"CC(=O)O.O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F","inchiKey":"RKXNZRPQSOPPRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLECAINIDE ACETATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL652","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flecainide acetate","Tambocor"],"synonyms":["Flecainide acetate","Flecainide monoacetate"],"crossReferences":{"DailyMed":["flecainide%20acetate"],"PubChem":["144207406","50106340","56422486","855927"],"chEBI":["5091"]},"count":2,"linkedTargets":{"rows":["ENSG00000183873"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200948","canonicalSmiles":"CC(CN(C)C)CN1c2ccccc2CCc2ccccc21.O=C(O)/C=C\\C(=O)O","inchiKey":"YDGHCKHAXOUQOS-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRIMIPRAMINE MALEATE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL644","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Surmontil","Trimipramine maleate"],"synonyms":["Trimipramine maleate"],"crossReferences":{"DailyMed":["trimipramine%20maleate"],"PubChem":["144204000","170465260","26732627","26747677","26747678","50107079","50107080","50107081"],"chEBI":["35030"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200973","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)CCC1CCCC1","inchiKey":"UOACKFBJUYNSLK-XRKIENNPSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTRADIOL CYPIONATE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Depo","Depo-estradiol","Estradiol cypionate"],"synonyms":["Estradiol 17.beta.-cyclopentanepropanoate","Estradiol cipionate","Estradiol cypionate","NSC-3354"],"crossReferences":{"DailyMed":["estradiol%20cypionate"],"PubChem":["144203554","144205884","144212135","170464789","46500620","69855"],"drugbank":["DB13954"],"chEBI":["34745"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201089","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"SPCKHVPPRJWQRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENHYDRAMINE CITRATE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL657","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diphenhydramine","Diphenhydramine citrate","Diphenhydramine laurylsulfate","Diphenhydramine tannate"],"crossReferences":{"DailyMed":["diphenhydramine%20citrate"]},"count":2,"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0003821","EFO_0003938","EFO_0003843","HP_0002018"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 2 investigational indications."}
{"id":"CHEMBL1201189","canonicalSmiles":"[13NH3]","inchiKey":"QGZKDVFQNNGYKY-BJUDXGSMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIA N 13","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1160819","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ammonia n 13"],"synonyms":["13n","Ammonia (13N)","Ammonia n 13","Ammonia n-13"],"crossReferences":{"DailyMed":["ammonia%20n-13"],"drugbank":["DB09326"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2007."}
{"id":"CHEMBL1201265","canonicalSmiles":"C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(=O)CCC(=O)O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12","inchiKey":"IMBXEJJVJRTNOW-XYMSELFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPREDNISOLONE HEMISUCCINATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methylprednisolone hemisuccinate","Methylprednisolone succinate"],"crossReferences":{"DailyMed":["methylprednisolone%20sodium%20succinate"],"PubChem":["124896649"],"drugbank":["DB14644"]},"childChemblIds":["CHEMBL1201081"],"count":1,"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0009267","EFO_0005952","MONDO_0002462","EFO_0000540","EFO_0000565","EFO_0000474","EFO_0002690","EFO_0003884","EFO_0004616","Orphanet_700","EFO_0005140","EFO_0008522","EFO_1001272","EFO_0000198","MONDO_0013730","EFO_0000694","EFO_0000685","EFO_0000220","Orphanet_701","EFO_0007537","EFO_1001466","EFO_0000222","EFO_0004194","EFO_0003894","EFO_0003843","EFO_0004599","EFO_0003106","EFO_0003885","HP_0100806","MP_0001845","EFO_0003840","MONDO_0100096","EFO_0000095","EFO_0000270","EFO_0007359","EFO_0000341","EFO_0001378","EFO_0003918","EFO_0001063"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and has 1 investigational indication."}
{"id":"CHEMBL1201321","canonicalSmiles":"N#CC(CCN1CCC(C(=O)O)(c2ccccc2)CC1)(c1ccccc1)c1ccccc1","inchiKey":"UFIVBRCCIRTJTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFENOXIN","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Difenoxin","MCN-JR-15,403-11","R 15,403 [AS HYDROCHLORIDE]","R-15403"],"crossReferences":{"DailyMed":["difenoxin%20hydrochloride"],"Wikipedia":["Difenoxin"],"drugbank":["DB01501"],"chEBI":["4534"]},"childChemblIds":["CHEMBL1200599"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0004798"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1978."}
{"id":"CHEMBL1201322","canonicalSmiles":"CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c1ncccn1","inchiKey":"IOYZYMQFUSNATM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THONZONIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112412"],"drugbank":["DB09552"]},"childChemblIds":["CHEMBL1200883"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1201345","canonicalSmiles":"CCCCC(CC)CCC(CC(C)C)OS(=O)(=O)O","inchiKey":"GROJOWHVXQYQGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRADECYL SULFURIC ACID","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tetradecyl sulfate"],"crossReferences":{"DailyMed":["sodium%20tetradecyl%20sulfate"],"PubChem":["29218059"],"drugbank":["DB11328"],"chEBI":["75275"]},"childChemblIds":["CHEMBL1200354"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946."}
{"id":"CHEMBL1201406","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C[C@@H](O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"JYILPERKVHXLNF-QMNUTNMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYNODIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ethynodiol"],"crossReferences":{"drugbank":["DB13866"],"chEBI":["50785"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201419","drugType":"Protein","blackBoxWarning":false,"name":"LUTROPIN ALFA","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Luveris"],"synonyms":["ATC G03 GA GONADOTROPINS","Luteinising hormone (human)","Lutropin alfa"],"crossReferences":{"DrugCentral":["4929"]},"count":3,"linkedTargets":{"rows":["ENSG00000138039"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0000545","EFO_0008560","MONDO_0018555"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 3 investigational indications."}
{"id":"CHEMBL1201562","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON BETA-1A","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avonex","Neoferon","Rebif"],"synonyms":["Interferon beta-1a"],"crossReferences":{"DailyMed":["interferon%20beta-1a"],"DrugCentral":["5139"],"Wikipedia":["Interferon_beta-1a"]},"count":12,"approvedIndications":["EFO_0003885"],"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000868","MONDO_0100130","EFO_0000249","EFO_0003929","EFO_0000384","EFO_0003106","EFO_0003885","MONDO_0100096","EFO_0000270","EFO_0000712","EFO_1001373","EFO_0000341","EFO_0007328","EFO_0003047"],"count":15},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for multiple sclerosis and has 11 investigational indications."}
{"id":"CHEMBL1201717","drugType":"Protein","blackBoxWarning":false,"name":"MECASERMIN RINFABATE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iplex","Somatokine"],"synonyms":["Mecasermin Rinfabate Recombinant","Mecasermin rinfabate","Mecasermin rinfabate recombinant","RHIGF-I/RHIGFBP-3"],"crossReferences":{"DrugCentral":["5197"]},"count":4,"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["Orphanet_206647","Orphanet_633","Orphanet_273","EFO_1001158"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 4 investigational indications."}
{"id":"CHEMBL1201774","canonicalSmiles":"C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(O)c2N1","inchiKey":"FNKQXYHWGSIFBK-RPDRRWSUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAPROPTERIN","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Daproterin","Sapropterin"],"crossReferences":{"DailyMed":["sapropterin%20dihydrochloride"],"Wikipedia":["Tetrahydrobiopterin"],"drugbank":["DB00360"],"chEBI":["59560"]},"childChemblIds":["CHEMBL1201775","CHEMBL1515624"],"count":10,"linkedTargets":{"rows":["ENSG00000171759"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","Orphanet_716","Orphanet_232","Orphanet_238583","EFO_0000249","EFO_0001645","EFO_0003758","EFO_1001461","EFO_0003876","EFO_0000666","EFO_0000537","EFO_0001422","HP_0012664","Orphanet_510","EFO_0003144","EFO_0003884","EFO_0000341","EFO_0005411","EFO_0000692","EFO_0004265"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 10 investigational indications."}
{"id":"CHEMBL1203919","canonicalSmiles":"Cl.NC(=O)c1cnc2n1CCc1ccccc1C21CCNCC1","inchiKey":"KPSVYNRQNRRDRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1203919","maximumClinicalTrialPhase":0,"parentId":"CHEMBL369075","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229937","canonicalSmiles":"O=C(CO)CO","inchiKey":"RXKJFZQQPQGTFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHYDROXYACETONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vitadye"],"synonyms":["Dihydroxyacetone"],"crossReferences":{"Wikipedia":["Dihydroxyacetone"],"drugbank":["DB01775"],"chEBI":["16016"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1230065","canonicalSmiles":"CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C","inchiKey":"GDTQLZHHDRRBEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-582949","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-582949","Bms-582949","PS-540446","Ps-540446"],"crossReferences":{"drugbank":["DB12696"]},"count":3,"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000676","EFO_0004264"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1230244","canonicalSmiles":"Nc1c(C(=O)O)ccc(Cl)c1O","inchiKey":"VWEPFJPQZFIOAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230244","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04598"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232111","canonicalSmiles":"C#CCN(C)CC1=Cc2ccccc2Oc2ccccc21","inchiKey":"QLMMOGWZCFQAPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMIGAPIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omigapil"],"crossReferences":{"PubChem":["174006533"],"drugbank":["DB12879"],"chEBI":["41778"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1237102","canonicalSmiles":"C[C@@H]1CN([C@H]2CC[C@](C#N)(c3ccc(F)cc3)CC2)CC[C@]1(C(=O)O)c1ccccc1.Cl","inchiKey":"OICFWWJHIMKBCD-VALQNVSPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOCABASTINE HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1615438","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Livostin"],"synonyms":["Levocabastine hydrochloride","R 50,547","R-50547"],"crossReferences":{"PubChem":["144204246","170465061","56463149"]},"count":1,"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_1001417"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993 and has 1 investigational indication."}
{"id":"CHEMBL1275711","canonicalSmiles":"CCCCCOc1ccc(-c2ccc(-c3ccc([14C](=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)cc5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)cc2)cc1","inchiKey":"JHVAMHSQVVQIOT-QWOZJQBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"14C-ANIDULAFUNGIN","maximumClinicalTrialPhase":0,"parentId":"CHEMBL264241","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["14C-Anidulafungin"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL129529","canonicalSmiles":"CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1","inchiKey":"HQFWVSGBVLEQGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTACAINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butacaine"],"crossReferences":{"PubChem":["11112305","124882226","144203979","170465459","26747049","855942"],"drugbank":["DB11502"]},"childChemblIds":["CHEMBL3142544"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL134","canonicalSmiles":"Clc1cccc(Cl)c1N=C1NCCN1","inchiKey":"GJSURZIOUXUGAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLONIDINE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Catapres","Catapres-tts-1","Catapres-tts-2","Catapres-tts-3","Clonidine"],"synonyms":["Catapres","Clonidine","Clorpres","Combipres","Duraclon","ST-155-BS","ST-155BS"],"crossReferences":{"DailyMed":["clonidine","clonidine%20hydrochloride"],"PubChem":["104171138","11110984","11110985","11113648","144203669","170464900","26751841","90341662"],"Wikipedia":["Clonidine"],"drugbank":["DB00575"],"chEBI":["3757"]},"childChemblIds":["CHEMBL1705"],"count":28,"approvedIndications":["EFO_0003821","EFO_0000516","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0004240","EFO_0003777","EFO_1001139","EFO_0002610","EFO_0000401","EFO_0005252","MONDO_0007254","EFO_0009267","EFO_0000274","EFO_0002950","EFO_0007191","EFO_1000783","EFO_0000289","EFO_0002506","EFO_0009514","HP_0001385","EFO_0003144","EFO_1000645","MONDO_0005299","EFO_0004616","EFO_0005799","EFO_0005230","EFO_1001904","EFO_0003888","EFO_0000616","EFO_0003756","HP_0002024","EFO_0003821","EFO_0005323","EFO_0009085","EFO_0000319","EFO_0003843","EFO_1000971","EFO_0000537","EFO_0000311","HP_0000713","EFO_0003890","Orphanet_230","EFO_0004895","EFO_0004273","EFO_0005611","EFO_0009523","MONDO_0043510","EFO_0000516","EFO_0000668","HP_0000023"],"count":46},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 3 approved and 25 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1364144","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"PLBHSZGDDKCEHR-LFYFAGGJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPREDNISOLONE ACETATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Depmedalone","Depo-medrol","Depo-medrone","M-predrol","Medrol","Medrol acetate","Methylprednisolone acetate","Neo-medrone"],"synonyms":["Methyl prednisolone acetate","Methylprednisolone 21-acetate","Methylprednisolone acetate","NSC-48985"],"crossReferences":{"DailyMed":["methylprednisolone%20acetate"],"PubChem":["144205275","50085428"],"chEBI":["6889"]},"count":8,"approvedIndications":["EFO_0000685","EFO_0002506","EFO_1000941"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_0000685","EFO_1001896","EFO_1001178","EFO_0003821","EFO_0004274","MONDO_0003541","EFO_1000941","EFO_1001909","EFO_1000653","EFO_0002506","MONDO_0002471","EFO_0004616","EFO_0004143","HP_0003419","MONDO_0004857"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 3 approved and 5 investigational indications."}
{"id":"CHEMBL1407356","canonicalSmiles":"CC(=O)N1C[C@H](O)C[C@H]1C(=O)O","inchiKey":"BAPRUDZDYCKSOQ-RITPCOANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXACEPROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxaceprol"],"crossReferences":{"PubChem":["144205705","170466355","57264330"],"drugbank":["DB13363"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL140830","canonicalSmiles":"CC(=O)N[C@@H]1[C@@H](O)C=C(C(=O)O)O[C@H]1[C@H](O)[C@H](O)CN","inchiKey":"VJTPBNUXDULDQD-UFGQHTETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL140830","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04227"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1447476","canonicalSmiles":"[Na+].[Na+].[O-]c1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1[O-]","inchiKey":"FNYZFZRGBBCWBI-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"BITHIONOLATE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL290106","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Dermatological toxicity"],"year":1967},"tradeNames":[],"synonyms":["Bithionolate sodium","Sodium bitionolate"],"crossReferences":{"PubChem":["144209989","26747892","26747893"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States  in 1967 due to Dermatological toxicity."}
{"id":"CHEMBL1463","canonicalSmiles":"Nc1[nH]c(=O)ncc1F","inchiKey":"XRECTZIEBJDKEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUCYTOSINE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alcobon","Ancoban","Ancobon","Ancotil","Flourocytosine","Flucytosine","Fluorocytosine"],"synonyms":["Flucytosine","NSC-103805","RO 2-9915","RO-2-9915","RO-29915"],"crossReferences":{"DailyMed":["flucytosine"],"PubChem":["11112505","144204066","170465407","174006933","405592","56424024","8139861"],"Wikipedia":["Flucytosine"],"drugbank":["DB01099"],"chEBI":["5100"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL151062","canonicalSmiles":"C[C@@H](O)c1ccccc1","inchiKey":"WAPNOHKVXSQRPX-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1-Phenyl-Ethanol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-Phenyl-Ethanol"],"crossReferences":{"drugbank":["DB04784"],"chEBI":["45616"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1532139","canonicalSmiles":"COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1.Cl.O","inchiKey":"INIDYCYXDNFBSV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1532139","maximumClinicalTrialPhase":0,"parentId":"CHEMBL142635","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56422151"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1535402","canonicalSmiles":"Br.CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21","inchiKey":"GAUWIDFICGEZKR-JUOYHRLASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1535402","maximumClinicalTrialPhase":0,"parentId":"CHEMBL298406","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26753271"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL155265","canonicalSmiles":"O=[N+]([O-])c1cc2nc(O)c(O)nc2cc1[N+](=O)[O-]","inchiKey":"RWVIMCIPOAXUDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DNQX","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNQX"],"crossReferences":{"PubChem":["50104334","90341758"],"drugbank":["DB03759"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1572280","canonicalSmiles":"Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1.O=C([O-])c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"ZFWFZMYQXOKWIY-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1572280","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1201303","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26748230","56463155"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1624","canonicalSmiles":"N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O","inchiKey":"XUIIKFGFIJCVMT-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVOTHYROXINE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Levothyroxine","NSC-36397"],"crossReferences":{"DailyMed":["levothyroxine%20sodium"],"PubChem":["144205654","144212473","170465450","26757755","8139892"],"Wikipedia":["Levothyroxine"],"drugbank":["DB00451"],"chEBI":["18332"]},"childChemblIds":["CHEMBL3989492","CHEMBL2103741","CHEMBL3989736"],"count":7,"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_0006859","MONDO_0002108","EFO_0004283","EFO_0003843","EFO_0004237","Orphanet_309005","EFO_0002950","Orphanet_442","EFO_0000289","EFO_0002690","EFO_0002892","EFO_1001062","EFO_0000400","EFO_1000931","EFO_0004705"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743061","drugType":"Antibody","blackBoxWarning":false,"name":"RAFIVIRUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CR-57","Rafivirumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1764","canonicalSmiles":"COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2","inchiKey":"VRQVVMDWGGWHTJ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMEPROMAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Levomepromazine","Levoprome","Nirvan","Tisercin"],"synonyms":["CL 36467","CL 39743","CL-36467","CL-39743","Levomepromazine","Methotrimeprazine","N05AA02","NSC-226516","RP 7044","RP-7044","SK&F 5116","SK&F-5116","XP-03","XP03"],"crossReferences":{"Wikipedia":["Levomepromazine"],"drugbank":["DB01403"],"chEBI":["6838"]},"childChemblIds":["CHEMBL2104973","CHEMBL1725730"],"count":5,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0005407","EFO_0005230","EFO_0000692"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for psychosis and has 4 investigational indications."}
{"id":"CHEMBL1874002","canonicalSmiles":"C/C(=C(/CCOC(=O)C(C)C)SS/C(CCOC(=O)C(C)C)=C(\\C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N","inchiKey":"CKHJPWQVLKHBIH-GPAWKIAZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1874002","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50112710"],"drugbank":["DB13416"],"chEBI":["31290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL189938","canonicalSmiles":"COc1ccc(NC2=C(c3ccccc3)C(=O)N(Cc3ccccc3)C2=O)cc1","inchiKey":"HLZMYWLMBBLASX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL189938","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08063"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL191896","canonicalSmiles":"CCCCCCCC/C=C/CCCCCCCC(=O)OCC(O)COP(=O)([O-])O.[Na+]","inchiKey":"XGRLSUFHELJJAB-RRABGKBLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OLEOYL","maximumClinicalTrialPhase":2,"parentId":"CHEMBL189959","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oleoyl"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1922235","canonicalSmiles":"COc1ccc(C(=O)Nc2cccc(O)c2NC(=O)c2ccc(N3CCCN(C)CC3)cc2)cc1","inchiKey":"IJNIQYINMSGIPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAREXABAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darexaban","YM-150","YM150"],"crossReferences":{"drugbank":["DB12289"]},"childChemblIds":["CHEMBL1922345","CHEMBL3527359"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1944698","canonicalSmiles":"CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1","inchiKey":"VXBAJLGYBMTJCY-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOTIRACICLIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EX45","SB-1317","SB1317","TG02","Tg-02","Tg02","Zotiraciclib"],"childChemblIds":["CHEMBL4298173"],"count":5,"linkedTargets":{"rows":["ENSG00000096968","ENSG00000123374","ENSG00000134058","ENSG00000136807","ENSG00000170312","ENSG00000122025"],"count":6},"linkedDiseases":{"rows":["EFO_0000095","EFO_0000182","EFO_1001465","EFO_1000657","EFO_0000519"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1968682","canonicalSmiles":"OCC(S)CS.[Bi]","inchiKey":"OAIWQXFETFYYAL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1968682","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1597","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["541179"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL200177","canonicalSmiles":"CCn1ncnc1COc1nn2c(-c3ccccc3F)nnc2cc1C(C)(C)C","inchiKey":"QKIWQBLNTSQOLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0777","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK0777","Mk-0777","Mk0777","TPA-023","TPA023"],"crossReferences":{"drugbank":["DB12238"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2019090","canonicalSmiles":"CCc1c(C)cc(C(=O)NC2(C(=O)O)CCCCC2)c(=O)n1Cc1ccc(F)cc1","inchiKey":"JIYXOJFSPOFZPY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-777469","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-777469"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2041980","canonicalSmiles":"CS(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc(C(F)(F)F)nc3)c2)cc1","inchiKey":"RTJQABCNNLMCJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MMV-390048","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["J3.367.891F","Mmv-390048"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2096660","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMARIUM SM 153 LEXIDRONAM PENTASODIUM","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110561","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Quadramet"],"synonyms":["153sm","CYT-424","Samarium (153 sm) lexidronam pentasodium","Samarium (153Sm) Lexidronam","Samarium (153Sm) Lexidronam Pentasodium","Samarium (153sm) lexidronam","Samarium sm 153 lexidronam pentasodium","Samarium sm 153 lexidronam pentasodium salt","Samarium sm-153 lexidronam pentasodium"],"crossReferences":{"DailyMed":["samarium%20sm-153%20lexidronam%20pentasodium"],"DrugCentral":["4533"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL2104449","canonicalSmiles":"CC(=O)N(O)CC1=C(n2ccccc2=O)c2cc(C(F)(F)F)ccc2OC1(C)C","inchiKey":"FXRJKZVWFJSKGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARAKALIM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RS-91309","Sarakalim"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105619","canonicalSmiles":"CC[C@H](OC(C)=O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"XBMIVRRWGCYBTQ-GCJKJVERSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETACETYLMETHADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Betacetylmethadol"],"crossReferences":{"drugbank":["DB01522"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105676","canonicalSmiles":"CC(OC(=O)c1ccc(Cc2c([O-])c3ccccc3oc2=O)cc1)(C(F)(F)F)C(F)(F)F.[Na+]","inchiKey":"DTAROZQXDYVCQR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TECARFARIN SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2105664","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["60 TIS 99","60-TIS-99","ATI-5923","ATI-5923 SODIUM SALT","Tecarfarin sodium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105997","canonicalSmiles":"O=C([O-])C1=C(CSc2nnnn2CS(=O)(=O)O)CS[C@@H]2[C@H](NC(=O)[C@H](O)c3ccccc3)C(=O)N12.[Na+]","inchiKey":"WZTUULPOBSTZKR-CFOLLTDRSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFONICID MONOSODIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1601","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefonicid monosodium","SK&F D-75073-Z"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106471","canonicalSmiles":"OCC1COC(CI)O1","inchiKey":"NEIPZWZQHXCYDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOMIODOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Domiodol","M.G. 13608"],"crossReferences":{"drugbank":["DB13768"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107572","canonicalSmiles":"COc1cccc([C@@H](C)NCCCc2ccccc2Cl)c1.Cl","inchiKey":"YJXUXANREVNZLH-PFEQFJNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECALCET HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL292376","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Norcalcin","Norcalin"],"synonyms":["KRN-568","NPS R-568","R-568","Tecalcet hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107829","canonicalSmiles":"Cl.NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1","inchiKey":"BPZWRYOUJMDQSY-PKLMIRHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMIXUSTAT HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2107821","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Acu-4429 hcl"],"synonyms":["ACU-4429 HCL","ACU-4429 HYDROCHLORIDE","Emixustat hydrochloride"],"linkedTargets":{"rows":["ENSG00000116745"],"count":1},"linkedDiseases":{"rows":["EFO_0009322"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2107846","drugType":"Protein","blackBoxWarning":false,"name":"DULANERMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-951","APO2L/TRAIL","Dulanermin"],"count":3,"linkedTargets":{"rows":["ENSG00000120889","ENSG00000104689"],"count":2},"linkedDiseases":{"rows":["EFO_1001480","EFO_0005952","EFO_0003060","EFO_1001951"],"count":4},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107880","drugType":"Antibody","blackBoxWarning":false,"name":"REGAVIRUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MCA-C23","Regavirumab","TI-23"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108015","drugType":"Unknown","blackBoxWarning":false,"name":"VITAMIN B COMPLEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Becotin","Becozym","Betalin complex","Betalin compound"],"synonyms":["Vitamin b complex"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108627","drugType":"Gene","blackBoxWarning":false,"name":"VOCIMAGENE AMIRETROREPVEC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TOCA 511","TOCA-511","Vocimagene amiretrorepvec"],"count":5,"description":"Gene drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108658","drugType":"Antibody","blackBoxWarning":false,"name":"TREMELIMUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-675,206","CP-675206","PF-06753388","TICILIMUMAB","Ticilimumab","Tremelimumab","Tremelimumab (genetical recombination)"],"count":56,"linkedTargets":{"rows":["ENSG00000163599"],"count":1},"linkedDiseases":{"rows":["EFO_0003891","EFO_0000365","EFO_0001075","MONDO_0003890","EFO_0000756","EFO_0000681","MONDO_0044704","EFO_1001951","MONDO_0001416","EFO_0000588","EFO_0000389","MONDO_0008903","EFO_1000251","EFO_0000182","EFO_0008528","EFO_0000501","EFO_0000641","EFO_0000514","MONDO_0003001","EFO_0000198","EFO_0002618","EFO_0001642","MONDO_0002108","MONDO_0008170","EFO_1001968","EFO_0005221","MONDO_0008315","EFO_1001100","EFO_0004284","EFO_0000574","EFO_0006544","EFO_0001378","MONDO_0015686","MONDO_0007254","EFO_0000708","EFO_0000305","MONDO_0001187","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0002158","EFO_0000673","EFO_0002617","EFO_0000616","EFO_0005220","MONDO_0021656","EFO_1000616","EFO_0000503","EFO_0000478","EFO_0000403","MONDO_0003002","MONDO_0007576","EFO_0000313","EFO_0003060","EFO_0000311","EFO_1001961","EFO_0003863","EFO_0002517","EFO_0000764","EFO_0000702","EFO_0000199","MONDO_0002367","EFO_0004142","MONDO_0024880","EFO_0000691","EFO_0000181","EFO_0000519"],"count":67},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 56 investigational indications."}
{"id":"CHEMBL2108722","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGADRICASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pegadricase","SEL-037","Sel-037","URICASE-PEG 20","URICASE-PEG-20","URICASE-PEG20"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109036","drugType":"Antibody","blackBoxWarning":false,"name":"IGOVOMAB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Inadmacis-125"],"synonyms":["Igovomab","OC-125"],"description":"Antibody drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2109171","drugType":"Protein","blackBoxWarning":false,"name":"DIBOTERMIN ALFA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dibotermin alfa","Inductos","Nebotermin"],"crossReferences":{"DrugCentral":["5024"]},"count":1,"approvedIndications":["EFO_0004260"],"description":"Protein drug with a maximum clinical trial phase of IV and is indicated for bone disease."}
{"id":"CHEMBL2109281","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7600","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DMOT4039A","RG-7600"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109322","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-820","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-820","Amg-820"],"count":4,"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0003060","EFO_0000311","EFO_1001951"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109377","drugType":"Antibody","blackBoxWarning":false,"name":"PAMREVLUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FG-3019","Pamrevlumab"],"count":6,"linkedTargets":{"rows":["ENSG00000118523"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","EFO_0002618","MONDO_0100096","EFO_0000768","EFO_0004236","EFO_0000400","EFO_0004239"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2109381","drugType":"Antibody","blackBoxWarning":false,"name":"BHQ-880","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BHQ-880","BHQ880","Bhq-880"],"count":1,"linkedTargets":{"rows":["ENSG00000107984"],"count":1},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109386","drugType":"Antibody","blackBoxWarning":false,"name":"CHTNT-1 131I","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHTNT-1","Chtnt-1 131i"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109450","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-811","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-811","Amg-811"],"count":1,"linkedTargets":{"rows":["ENSG00000111537"],"count":1},"linkedDiseases":{"rows":["EFO_0000676"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109549","drugType":"Antibody","blackBoxWarning":false,"name":"J591","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUJ-591","HUJ591-GS","J591","Rosopatamab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109623","drugType":"Antibody","blackBoxWarning":false,"name":"STX-100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["STX-100","Stx-100"],"count":1,"linkedTargets":{"rows":["ENSG00000138448","ENSG00000115221"],"count":2},"linkedDiseases":{"rows":["EFO_0000768"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110829","canonicalSmiles":"Cc1cccc(Cc2c[nH]cn2)c1C","inchiKey":"RHDJRPPFURBGLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DETOMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Detomidine"],"crossReferences":{"drugbank":["DB11556"]},"childChemblIds":["CHEMBL2106210"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL212218","canonicalSmiles":"Cc1cc(S(=O)(=O)c2c([N+](=O)[O-])cc(C(F)(F)F)cc2[N+](=O)[O-])c(Cl)cc1Cl","inchiKey":"INAZPZCJNPPHGV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL212218","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07620"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL220320","canonicalSmiles":"O=C(NCc1ccccc1)c1cc(-c2n[nH]cc2-c2cccc(Cl)c2)c[nH]1","inchiKey":"PDJZASCRQRBYQS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220320","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07010"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2219640","canonicalSmiles":"[Cl-].[Cl-].[Sr+2]","inchiKey":"AHBGXTDRMVNFER-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"STRONTIUM CHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Strontium chloride"],"crossReferences":{"DailyMed":["strontium%20chloride%20sr-89"],"drugbank":["DB13987"],"chEBI":["36383"]},"childChemblIds":["CHEMBL1200625","CHEMBL2105878","CHEMBL1909080"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993."}
{"id":"CHEMBL2220486","canonicalSmiles":"CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12","inchiKey":"CUDVHEFYRIWYQD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUCITANIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-3810","Al-3810","CO-3810","E-3810","Lucitanib","S 80881","S-80881"],"crossReferences":{"drugbank":["DB11845"],"chEBI":["65209"]},"childChemblIds":["CHEMBL2180605"],"count":5,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000066468","ENSG00000102755","ENSG00000037280","ENSG00000077782"],"count":5},"linkedDiseases":{"rows":["MONDO_0001416","EFO_0000616","EFO_0000702","MONDO_0007254","EFO_0003060","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL222280","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br","inchiKey":"WOVKYSAHUYNSMH-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROXURIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Broxuridine","NSC-38297"],"crossReferences":{"PubChem":["144204567","144207304","170465870","17389223","29215103","50105447","50105448","56463513","90341500"],"Wikipedia":["Bromodeoxyuridine"],"drugbank":["DB12028"],"chEBI":["472552"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL225057","canonicalSmiles":"CN1CCC[C@H]1c1cccnc1.Cl","inchiKey":"HDJBTCAJIMNXEW-PPHPATTJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nicotine HCl"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL226267","canonicalSmiles":"COc1ccc(-c2sc3cc(O)ccc3c2Oc2ccc(OCCN3CCCCC3)cc2)cc1","inchiKey":"MCGDSOGUHLTADD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARZOXIFENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arzoxifene","LY353381"],"crossReferences":{"Wikipedia":["Arzoxifene"],"drugbank":["DB06249"]},"childChemblIds":["CHEMBL2105949"],"count":4,"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["Orphanet_145","EFO_0003869","EFO_0003854","MONDO_0008170","MONDO_0011962","MONDO_0007254","MONDO_0002087","EFO_0003882"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL231068","canonicalSmiles":"O=c1[nH]c2ccccc2n1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1","inchiKey":"PPRRDFIXUUSXRA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLIBANSERIN","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Addyi"],"synonyms":["BIMT 17","BIMT 17 BS","BIMT-17","BIMT-17-BS","Flibanserin"],"crossReferences":{"DailyMed":["flibanserin"],"Wikipedia":["Flibanserin"],"drugbank":["DB04908"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL235191","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)Nc2ccccc2N)cc1","inchiKey":"VAZAPHZUAVEOMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TACEDINALINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-994","GOE 5549","GOE-5549","PD 123654","PD-123654","Tacedinaline"],"crossReferences":{"drugbank":["DB12291"],"chEBI":["90195"]},"count":3,"linkedTargets":{"rows":["ENSG00000108840","ENSG00000094631","ENSG00000061273","ENSG00000163517","ENSG00000147099","ENSG00000100429","ENSG00000116478","ENSG00000068024","ENSG00000171720","ENSG00000048052","ENSG00000196591"],"count":11},"linkedDiseases":{"rows":["EFO_0002618","MONDO_0008903","EFO_0001378"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2364655","drugType":"Antibody","blackBoxWarning":false,"name":"EVOLOCUMAB","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Repatha","Repatha sureclick"],"synonyms":["AMG-145","Evolocumab"],"crossReferences":{"DailyMed":["evolocumab"],"DrugCentral":["5000"]},"count":12,"approvedIndications":["Orphanet_391665","EFO_0000319","EFO_0004911"],"linkedTargets":{"rows":["ENSG00000169174"],"count":1},"linkedDiseases":{"rows":["HP_0002140","HP_0003124","EFO_0001645","EFO_0000556","EFO_0003774","EFO_0000319","EFO_0004911","Orphanet_309005","EFO_0002615","HP_0100806","EFO_0003914","MP_0001845","HP_0012664","EFO_0008585","Orphanet_412","EFO_0003144","EFO_0003884","Orphanet_79211","Orphanet_391665","EFO_0000400","EFO_0005672","EFO_0004265"],"count":22},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 9 investigational indications."}
{"id":"CHEMBL2365712","canonicalSmiles":"CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12","inchiKey":"SEALOBQTUQIVGU-QNIJNHAOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2365712","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11273"],"chEBI":["59909"]},"childChemblIds":["CHEMBL2356227"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2442750","canonicalSmiles":"Cc1c(CC(=O)O)c2cccnc2n1Cc1ccc(S(C)(=O)=O)cc1","inchiKey":"YOPFAMROKXHVCQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QAV680","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NVP-QAV680","QAV680","QAV690 FREE ACID","Qav680"],"crossReferences":{"drugbank":["DB11658"]},"count":3,"linkedTargets":{"rows":["ENSG00000183134"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0000270","EFO_0003956"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL247767","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](NC(=O)N[C@@H](Cc1ccccc1)C(=O)O)C1CCNC(=N)N1)C(=O)N[C@H](C=O)Cc1ccccc1","inchiKey":"MRXDGVXSWIXTQL-HYHFHBMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHYMOSTATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chymostatin"],"crossReferences":{"drugbank":["DB01683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL248176","canonicalSmiles":"CCNC(=O)N1CCC(Nc2ncc(Cl)c(-c3c[nH]c4ccccc34)n2)CC1","inchiKey":"ARMFMDYRYOKSOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL248176","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08005"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253608","canonicalSmiles":"Cc1cc(C(=O)Nc2cc(Cl)cc(N3CCCCC3)c2)cc(C)c1OCCN","inchiKey":"JDYIYIRPQKMWMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253608","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08697"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL262103","canonicalSmiles":"CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)OC)[C@@H](C)CC","inchiKey":"XGWSRLSPWIEMLQ-YTFOTSKYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL262103","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26756809"],"drugbank":["DB07223"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL265758","canonicalSmiles":"Nc1nc(O)c2nn(-c3cccc(C(=O)O)c3)nc2n1","inchiKey":"KNLLRZNGRRRPEW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL265758","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01906"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275311","canonicalSmiles":"C/C(=C\\c1ccc(C(=O)O)cc1)c1ccc2c(c1)C(C)(C)CCC2(C)C","inchiKey":"FOIVPCKZDPCJJY-JQIJEIRASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Ro-137410","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ro-137410"],"crossReferences":{"PubChem":["11111877","11113689","124881633","251919756","26751878","26751880","26751881","50104564","56463204","85231254","90341737"],"drugbank":["DB02877"],"chEBI":["75261"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282575","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"UYIFTLBWAOGQBI-BZDYCCQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRADIOL BENZOATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benztrone","Progynon b oleoso"],"synonyms":["Benzestrofol","Benzogynestryl","Beta-estradiol benzoate","Difolliculin","Estradiol benzoate","Estradiol monobenzoate","Follidrin","Oestradiol benzoate"],"crossReferences":{"PubChem":["144204419","29214996","855530"],"drugbank":["DB13953"],"chEBI":["77006"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL294199","canonicalSmiles":"COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O","inchiKey":"YKPUWZUDDOIDPM-SOFGYWHQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPSAICIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Qutenza","Zacin","Zostrix","Zostrix hp"],"synonyms":["ALGRX 4975","ALGRX-4975","Capsaicin","FEMA NO. 3404","NGX-1998","NGX-4010","NSC-56353","Ngx-1998"],"crossReferences":{"DailyMed":["capsaicin"],"PubChem":["104171351","124883045","124883047","124883049","124883050","124890089","144204368","144207513","17389996","26747263","26752818","26752819","26752820","50105473","56463572"],"Wikipedia":["Capsaicin"],"drugbank":["DB06774"],"chEBI":["3374"]},"count":27,"approvedIndications":["EFO_0005762","HP_0002829","HP_0003326","EFO_0009430","EFO_0002506","EFO_0005856","EFO_0003843","EFO_1000941","EFO_1001434"],"linkedTargets":{"rows":["ENSG00000196689"],"count":1},"linkedDiseases":{"rows":["EFO_1001896","MONDO_0001583","HP_0000989","EFO_0001361","HP_0012735","MONDO_0007254","Orphanet_213","EFO_0003913","HP_0002829","EFO_1000783","EFO_0009430","EFO_0002506","EFO_0000712","EFO_0009619","EFO_0004616","EFO_0000676","EFO_0000253","EFO_0006510","EFO_1000850","EFO_0009625","EFO_0005762","EFO_0005854","EFO_0008521","EFO_0006859","EFO_0005856","EFO_0003821","EFO_0009387","EFO_1001054","HP_0003394","EFO_0003843","EFO_1000941","MONDO_0008315","HP_0003326","EFO_0009364","EFO_0000764","MONDO_0043510","EFO_1001434"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 9 approved and 18 investigational indications."}
{"id":"CHEMBL295971","canonicalSmiles":"CO/C=C\\[C@H](N)C(=O)O","inchiKey":"HLOPMQJRUIOMJO-SWOZAWMQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL295971","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03611"],"chEBI":["40719"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3","canonicalSmiles":"CN1CCC[C@H]1c1cccnc1","inchiKey":"SNICXCGAKADSCV-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOTINE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Habitrol","Nicabate","Nicoderm","Nicoderm cq","Nicopass","Nicopatch","Nicorette invisi","Nicotine","Nicotinell classic","Nicotinell support","Nicotinell tts 10","Nicotinell tts 20","Nicotinell tts 30","Nicotrol","Nicotrol Inhaler","Nicotrol NS","Niquitin","Niquitin clr","Niquitin minis cherry","Niquitin minis mint","Niquitin minis orange","Niquitin mint","Niquitin pre-quit","Niquitin strips mint","Prostep","Stoppers","Stubit"],"synonyms":["Nicotine"],"crossReferences":{"DailyMed":["nicotine"],"PubChem":["144209012","144210494","17389805","26752744","26752745","26752746","50105392","50105393","56314824","90341453"],"Wikipedia":["Nicotine"],"drugbank":["DB00184"],"chEBI":["17688"]},"childChemblIds":["CHEMBL3137669","CHEMBL1448280","CHEMBL3989563","CHEMBL151515","CHEMBL3182465","CHEMBL225057","CHEMBL1201536"],"count":22,"approvedIndications":["EFO_0003768"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["MONDO_0004938","EFO_0002610","MONDO_0002009","EFO_0000249","DOID_13406","MONDO_0007254","MONDO_0004567","EFO_0003768","EFO_1001461","EFO_0004318","EFO_0003829","EFO_0007191","HP_0100543","MONDO_0002050","MONDO_0002974","EFO_0003144","MONDO_0008903","EFO_0000692","MONDO_0004647","Orphanet_797","EFO_0000694","EFO_0004319","EFO_0003888","EFO_0004329","EFO_0002508","EFO_0001645","Orphanet_3389","EFO_0000313","EFO_0003843","EFO_0000546","GO_0007568","MP_0001845","EFO_0001072","MONDO_0100096","EFO_0004888","EFO_0000341","HP_0000678","EFO_0001360","EFO_0000691","EFO_0005411"],"count":40},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for nicotine dependence and has 21 investigational indications."}
{"id":"CHEMBL311226","canonicalSmiles":"O[C@H]1CN2CC[C@H](O)[C@@H]2[C@@H](O)[C@@H]1O","inchiKey":"JDVVGAQPNNXQDW-TVNFTVLESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CASTANOSPERMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Castanospermine"],"crossReferences":{"PubChem":["11532892","26751872","26751873"],"Wikipedia":["Castanospermine"],"drugbank":["DB01816"],"chEBI":["27860"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3121539","canonicalSmiles":"CC1=CC[C@H](C(=O)N(c2cc(C#CC(C)(C)C)sc2C(=O)O)[C@H]2CC[C@](O)(CO[C@H]3CCOC3)CC2)CC1","inchiKey":"MUICUPWICXUNRS-GDCCIXDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RADALBUVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gs-9669","Radalbuvir"],"crossReferences":{"drugbank":["DB12065"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3126379","canonicalSmiles":"CC(=O)O.OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O","inchiKey":"MAOQPTVBPXCJLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3126379","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1263","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3133037","canonicalSmiles":"Cc1c(Cc2ccccc2)nnc(N2CCN(c3cnc(C(C)(C)O)cn3)[C@H](C)C2)c1C","inchiKey":"POERAARDVFVDLO-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEQ506","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LEQ-506","LEQ506","Leq 506","Leq506","NVP-LEQ506"],"crossReferences":{"drugbank":["DB12857"]},"count":2,"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0002939","EFO_0004193"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3133300","canonicalSmiles":"[3H]C1([3H])Oc2ccc(OC[C@@H]3CNCC[C@H]3c3ccc(F)cc3)cc2O1","inchiKey":"AHOUBRCZNHFOSL-FIAXMDQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3133300","maximumClinicalTrialPhase":0,"parentId":"CHEMBL490","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137315","canonicalSmiles":"Cn1c(C2(NC(=O)c3ccc4c(C5CCCC5)c(-c5ncc(Br)cn5)n(C)c4c3)CCC2)nc2ccc(/C=C/C(=O)[O-])cc21.[Na+]","inchiKey":"YJADTGFGJMFOLM-KJEVSKRMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"DELEOBUVIR SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2403318","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 207127 NA","BI-207127 NA","BI-207127 SODIUM SALT","BI-207127NA","Deleobuvir sodium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3182640","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.COc1ccc2c3c1O[C@H]1C(=O)CC[C@H]4[C@@H](C2)N(C)CC[C@]314.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"KOQRETHOLOHQJI-YPZORMFFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3182640","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1457","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205119"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186112","canonicalSmiles":"OCC(CO)(CO)CO","inchiKey":"WXZMFSXDPGVJKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186112","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209119","144213878"],"drugbank":["DB13526"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188355","canonicalSmiles":"C/C=C(C(=C/C)/c1ccc(OC(C)=O)cc1)\\c1ccc(OC(C)=O)cc1","inchiKey":"YWLLGDVBTLPARJ-OXAZHYLESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3188355","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170466708"],"drugbank":["DB14668"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL325372","canonicalSmiles":"COC(=O)c1ccc(O)cc1","inchiKey":"LXCFILQKKLGQFO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLPARABEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E218","Methyl p-hydroxybenzoate","Methyl parahydroxybenzoate","Methylparaben"],"crossReferences":{"PubChem":["144205169","144209516","144210329","170465480","26754470","50085960"],"Wikipedia":["Methylparaben"],"drugbank":["DB14212"],"chEBI":["31835"]},"childChemblIds":["CHEMBL2106903"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301624","canonicalSmiles":"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](C)NC1=O","inchiKey":"HDHDTKMUACZDAA-PHNIDTBTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SETMELANOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIM-22493","RM-493","Setmelanotide"],"crossReferences":{"drugbank":["DB11700"]},"count":4,"linkedTargets":{"rows":["ENSG00000166603"],"count":1},"linkedDiseases":{"rows":["HP_0000083","Orphanet_739","EFO_0001074","Orphanet_819","EFO_0001073"],"count":5},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3350389","canonicalSmiles":"[2H]C([2H])(N)C(=O)C([2H])([2H])CC(=O)O","inchiKey":"ZGXJTSGNIOSYLO-VEPVEJTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3350389","maximumClinicalTrialPhase":0,"parentId":"CHEMBL601","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL34474","canonicalSmiles":"COC(=O)C(C)Oc1ccc(Oc2ccc(Cl)cc2Cl)cc1","inchiKey":"BACHBFVBHLGWSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICLOFOP-METHYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211096","26757265"],"drugbank":["DB13918"],"chEBI":["4510"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544949","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N)CCCCN)C(C)C)C(N)=O","inchiKey":"VUYRSKROGTWHDC-HZGLMRDYSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CTCE-9908","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ctce-9908"],"description":"Protein drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3544977","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1[C@H](c2nc3cc(-c4cc5ccc4CCc4ccc(c(-c6ccc7[nH]c([C@@H]8C[C@@H]9CCCC[C@@H]9N8C(=O)[C@@H](NC(=O)OC)C(C)C)nc7c6)c4)CC5)ccc3[nH]2)C[C@@H]2CCCC[C@@H]21)C(C)C","inchiKey":"LSYBRGMTRKJATA-IVEWBXRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODALASVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACH-0143102","ACH-3102","Odalasvir"],"crossReferences":{"drugbank":["DB13041"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545009","drugType":"Small molecule","blackBoxWarning":false,"name":"PBF-509","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pbf-509"],"count":2,"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0002508","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545063","canonicalSmiles":"C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C.CS(=O)(=O)O","inchiKey":"FUKSNUHSJBTCFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSIMERTINIB MESYLATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3353410","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tagrisso"],"synonyms":["AZD-9291 MESYLATE","AZD9291 mesylate","Osimertinib mesilate","Osimertinib mesylate"],"crossReferences":{"DailyMed":["osimertinib%20mesylate"]},"count":1,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and has 1 investigational indication."}
{"id":"CHEMBL3545166","canonicalSmiles":"CS(=O)(=O)N(c1cc(F)cc(F)c1)C1CN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)C1","inchiKey":"IQQBRKLVEALROM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DRINABANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ave1625","Drinabant"],"count":2,"linkedTargets":{"rows":["ENSG00000118432"],"count":1},"linkedDiseases":{"rows":["EFO_0000249","EFO_0000692"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545171","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-05089771","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-05089771"],"count":4,"linkedTargets":{"rows":["ENSG00000169432"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","Orphanet_1956","EFO_0010072","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3545215","canonicalSmiles":"CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21","inchiKey":"JCINBYQJBYJGDM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-911543","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-911543","JAK2 INHIBITOR BMS-911543"],"crossReferences":{"drugbank":["DB12591"]},"count":1,"linkedTargets":{"rows":["ENSG00000096968"],"count":1},"linkedDiseases":{"rows":["EFO_0000311"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545394","drugType":"Small molecule","blackBoxWarning":false,"name":"DRF-10945","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Drf-10945"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL360376","canonicalSmiles":"O=C(CSc1nc(O)cc(C(F)(F)F)n1)N1CCCCC1","inchiKey":"UDBHGUOSOKOIAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360376","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03009"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL361078","canonicalSmiles":"Oc1ccc2c(-c3cc(Br)c(O)cc3O)noc2c1","inchiKey":"LZACPHWPRDKUPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL361078","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07502"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3668014","canonicalSmiles":"COc1cc(F)c(-n2c(=O)[nH]c3csc(C(=O)O)c3c2=O)cc1OCc1c(OC)ccc(F)c1F","inchiKey":"BMAAMIIYNNPHAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINZAGOLIX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KLH-2109","Klh-2109","Linzagolix","OBE-2109","OBE2109"],"childChemblIds":["CHEMBL4298171"],"count":3,"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001065","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707206","canonicalSmiles":"O=P([O-])([O-])OC(CO)CO.[Ca+2]","inchiKey":"UHHRFSOMMCWGSO-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM GLYCERYLPHOSPHATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1232903","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium glycerylphosphate"],"crossReferences":{"DrugCentral":["4434"],"drugbank":["DB11264"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707332","canonicalSmiles":"C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12.O=C1O[C@H]([C@@H](O)CO)C(O)=C1O.O=C1O[C@H]([C@@H](O)CO)C(O)=C1O","inchiKey":"CJHQUYQRCLIWSW-JPGAVJPLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUININE ASCORBATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL170","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quinine ascorbate","Quinine biascorbate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707342","canonicalSmiles":"O=C([O-])c1ccccc1O.[K+]","inchiKey":"FRMWBRPWYBNAFB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM SALICYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Potassium salicylate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707377","canonicalSmiles":"C=C1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O","inchiKey":"CKFBRGLGTWAVLG-GOMYTPFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEGESTERONE ACETATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nestorone"],"synonyms":["Elcometrine","ST-1435","Segesterone acetate"],"crossReferences":{"DailyMed":["segesterone%20acetate"],"drugbank":["DB14583"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018."}
{"id":"CHEMBL3775741","drugType":"Small molecule","blackBoxWarning":false,"name":"AMMONIUM TETRATHIOMOLYBDATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4301078","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATT-M","ATTM","Ammonium tetrathiomolybdate","NSC-286644","NSC-714598","Tiomolibdate diammonium"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3833346","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"TOFERSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-067","BIIB067","Biib067","ISIS-SOD1Rx","Tofersen"],"count":1,"linkedTargets":{"rows":["ENSG00000142168"],"count":1},"linkedDiseases":{"rows":["EFO_0000253"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3833378","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O.CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCN(CCO)CC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12","inchiKey":"MEGKRPMNPGTIIG-VNYBMUHKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENIMEPICYCLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Penimepicycline"],"crossReferences":{"DrugCentral":["2084"],"drugbank":["DB13264"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL38397","canonicalSmiles":"N[C@@H](CC(C(=O)O)C(=O)O)C(=O)O","inchiKey":"UHBYWPGGCSDKFX-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL38397","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03847"],"chEBI":["41450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL396298","canonicalSmiles":"COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3cccc4c(=O)c5cccc(OC)c5[nH]c34)cc1)CC2","inchiKey":"OSFCMRGOZNQUSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELACRIDAR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elacridar"],"crossReferences":{"PubChem":["137276063"],"drugbank":["DB04881"]},"childChemblIds":["CHEMBL569424","CHEMBL2074730"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989480","canonicalSmiles":"O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Mg+2].[Mg+2].[Mg+2]","inchiKey":"PLSARIKBYIPYPF-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM CITRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Citramag","Mag cit","Mag diasporal 300","Magcit"],"synonyms":["Magnesium citrate","NSC-83517"],"crossReferences":{"drugbank":["DB11110"]},"count":3,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 2 investigational indications."}
{"id":"CHEMBL3989509","canonicalSmiles":"CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C.CC(O)C(=O)O","inchiKey":"QNLDTXPVZPRSAM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAZOCINE LACTATE","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL100116","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Talwin"],"synonyms":["Pentazocine lactate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1967."}
{"id":"CHEMBL3989724","canonicalSmiles":"CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl","inchiKey":"ZIIJJOPLRSCQNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLURAZEPAM HYDROCHLORIDE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL968","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dalmane","Flurazepam hydrochloride"],"synonyms":["Flurazepam","Flurazepam hydrochloride","RO 5-6901"],"crossReferences":{"DailyMed":["flurazepam%20hydrochloride"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1970. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989845","canonicalSmiles":"CN(C)CCCN1c2ccccc2CCc2ccccc21.CN(C)CCCN1c2ccccc2CCc2ccccc21.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"BPQZYOJIXDMZSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IMIPRAMINE PAMOATE","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL11","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imipramine pamoate","Tofranil-pm"],"synonyms":["Imipramine pamoate"],"crossReferences":{"DailyMed":["imipramine%20pamoate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989986","drugType":"Antibody","blackBoxWarning":true,"name":"RAVULIZUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ultomiris"],"synonyms":["ALXN-1210","ALXN1210","Ravulizumab","Ravulizumab-cwvz"],"crossReferences":{"DailyMed":["ravulizumab-cwvz"]},"count":9,"approvedIndications":["EFO_0000540","Orphanet_447"],"linkedTargets":{"rows":["ENSG00000106804"],"count":1},"linkedDiseases":{"rows":["EFO_0004610","Orphanet_2134","EFO_0004256","EFO_0000253","EFO_0007541","EFO_0004991","EFO_1000637","EFO_0000540","Orphanet_183589","Orphanet_447"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for immune system disease and paroxysmal nocturnal hemoglobinuria and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3990041","drugType":"Gene","blackBoxWarning":false,"name":"NADOFARAGENE FIRADENOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Instiladrin"],"synonyms":["Nadofaragene firadenovec","rAd-IFN","rAd-IFN-2b"],"count":2,"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3991432","drugType":"Unknown","blackBoxWarning":false,"name":"LUTETIUM DOTATATE","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["lutetium%20dotatate%20lu-177"]},"childChemblIds":["CHEMBL3989924"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000132671","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":5},"linkedDiseases":{"rows":["MONDO_0002120","EFO_1001901","MONDO_0024503","Orphanet_2495","EFO_0000621","EFO_1000045"],"count":6},"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 2018."}
{"id":"CHEMBL4166742","canonicalSmiles":"Cl.O=C(O)CNC(=O)c1c(O)cc(CCc2ccccc2)n2ncnc12","inchiKey":"BPZAJOSLAXGKFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4166742","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4297619","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL419213","canonicalSmiles":"NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O.O.O","inchiKey":"CZRQXSDBMCMPNJ-ZUIPZQNBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LISINOPRIL","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1237","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acemin","Carace","Lisinopril","Lisopress","Prinivil","Qbrelis","Zestril"],"synonyms":["Lisinopril","MK-521"],"crossReferences":{"PubChem":["11113057","170464907"],"chEBI":["6503"]},"count":4,"approvedIndications":["EFO_0000373","EFO_0000612","EFO_0000319","EFO_0000537"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000373","EFO_0000612","EFO_0000319","EFO_0000537"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 4 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL423","canonicalSmiles":"CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1","inchiKey":"NWIUTZDMDHAVTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAXOLOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betoptic","Betoptic susp"],"synonyms":["ALO-140102 FREE BASE","Betaxolol","Betoptic","Kerledex","Kerlone","SL-7521210 FREE BASE"],"crossReferences":{"DailyMed":["betaxolol%20hydrochloride"],"PubChem":["144203642","170465448","90341580"],"Wikipedia":["Betaxolol"],"drugbank":["DB00195"],"chEBI":["3082"]},"childChemblIds":["CHEMBL1691"],"count":4,"approvedIndications":["EFO_0000319","EFO_0000516"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_0000319","EFO_0000516"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for glaucoma and cardiovascular disease and has 2 investigational indications."}
{"id":"CHEMBL4297183","canonicalSmiles":"CN1Cc2cc(Cl)ccc2-n2c(nnc2[C@H]2CC[C@H](Oc3ccccn3)CC2)C1","inchiKey":"GMPZPHGHNDMRKL-RZDIXWSQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALOVAPTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balovaptan","RG-7314","RG7314","RO-5285119","RO5285119","Rg7314"],"crossReferences":{"drugbank":["DB14823"]},"count":1,"linkedTargets":{"rows":["ENSG00000166148"],"count":1},"linkedDiseases":{"rows":["EFO_0003756"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297205","drugType":"Small molecule","blackBoxWarning":false,"name":"PADOPORFIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Padoporfin","WST-09","WST09","Wst09"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297262","canonicalSmiles":"CCCCCCCCCCCCCCCCCCCC(=O)N[C@H]1CC[C@@]2(C)[C@@H](C1)C[C@@H](O)[C@@H]1[C@@H]2C[C@H](O)[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCC(=O)O","inchiKey":"SHKXZIQNFMOPBS-OOMQYRRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARAMCHOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aramchol"],"crossReferences":{"drugbank":["DB11860"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297293","canonicalSmiles":"Clc1ccc(-c2nn(Cc3ccccc3)c3c2CCNCC3)cc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"DIQZMBPDLFAJLK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"JNJ-18038683","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4205783","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-18038683"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297395","name":"CHEMBL4297395","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11848"]}}
{"id":"CHEMBL4297416","canonicalSmiles":"Cn1nccc1-c1ccc(Sc2cccc(C3(C(N)=O)CCOCC3)c2)cc1","inchiKey":"DVNQWYLVSNPCJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-4191834","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04191834","Pf-4191834"],"crossReferences":{"drugbank":["DB11645"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297467","canonicalSmiles":"Nc1ccc(/C=C/C(=O)NCc2cc3cc(-c4ccc(C(=O)N5CCC(F)(F)CC5)cc4)cc(-c4ccc(F)cc4)c3o2)cn1","inchiKey":"MRFOPLWJZULAQD-SWGQDTFXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KPT-9274","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KPT-9274","Kpt 9274","Kpt-9274"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297555","drugType":"Unknown","blackBoxWarning":false,"name":"RESIMMUNE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-dmdt390-bisfv(ucht1)","LAX-699","Resimmune"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297692","drugType":"Unknown","blackBoxWarning":false,"name":"ALX-0171","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALX-0171","ALX0171","Alx-0171","Gontivimab"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297698","drugType":"Unknown","blackBoxWarning":false,"name":"AVI-7537","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avi-7537"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297768","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"IDRABIOTAPARINUX SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Idrabiotaparinux sodium"],"count":3,"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297920","drugType":"Antibody","blackBoxWarning":false,"name":"TIMOLUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTT-1023","Btt-1023","Timolumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL43184","canonicalSmiles":"Nc1c2ccccc2nc2ccccc12","inchiKey":"XJGFWWJLMVZSIG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMINACRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["9-Aminoacridine","Aminoacridine"],"crossReferences":{"PubChem":["26748404","26748405","50107395"],"Wikipedia":["9-Aminoacridine"],"drugbank":["DB11561"],"chEBI":["74789"]},"childChemblIds":["CHEMBL1308088","CHEMBL1330022"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL435966","canonicalSmiles":"O=[N+]([O-])c1cncn1CCN1CCOCC1","inchiKey":"MDJFHRLTPRPZLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIMORAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Naxogin 500"],"synonyms":["K-1900","NSC-107524","Nimorazole"],"crossReferences":{"PubChem":["170466578","92764328"],"drugbank":["DB12172"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL446061","canonicalSmiles":"OCCN(CCO)CCO","inchiKey":"GSEJCLTVZPLZKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TROLAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mobisyl [as salicylate]","Xerumenex"],"synonyms":["NSC-36718","Triethanolamine","Trolamine"],"crossReferences":{"PubChem":["144206717","144209260","144210845","26754496","29215347"],"Wikipedia":["Triethanolamine"],"drugbank":["DB13747"],"chEBI":["28621"]},"count":1,"approvedIndications":["HP_0200042"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for skin ulcer."}
{"id":"CHEMBL4465601","canonicalSmiles":"[2H]c1c([2H])c([2H])c(C2=C(c3ccc(S(C)(=O)=O)cc3)COC2=O)c([2H])c1[2H]","inchiKey":"RZJQGNCSTQAWON-VIQYUKPQSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4465601","maximumClinicalTrialPhase":0,"parentId":"CHEMBL122","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4476089","canonicalSmiles":"[2H]C([2H])([2H])C([2H])(Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)C([2H])([2H])[2H]","inchiKey":"VERWOWGGCGHDQE-WFBMWZOZSA-N","drugType":"unknown","blackBoxWarning":false,"name":"CHEMBL4476089","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2403108","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Unknown drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL448343","canonicalSmiles":"NC[C@@H](F)C[PH](=O)O","inchiKey":"LJNUIEQATDYXJH-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LESOGABERAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-3355","AZD3355","Azd3355","Lesogaberan"],"crossReferences":{"Wikipedia":["Lesogaberan"],"drugbank":["DB11920"]},"count":1,"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["EFO_0003948"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL44884","canonicalSmiles":"CC[C@@H](CO)NCCN[C@@H](CC)CO","inchiKey":"AEUTYOVWOVBAKS-UWVGGRQHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHAMBUTOL","yearOfFirstApproval":1967,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Ethambutol"],"crossReferences":{"DailyMed":["ethambutol%20hydrochloride"],"TG-GATEs":["83"],"Wikipedia":["Ethambutol"],"drugbank":["DB00330"],"chEBI":["4877"]},"childChemblIds":["CHEMBL1788373","CHEMBL3140361","CHEMBL1628240"],"count":6,"approvedIndications":["Orphanet_3389"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1967 and is indicated for tuberculosis and has 5 investigational indications."}
{"id":"CHEMBL4594464","drugType":"Unknown","blackBoxWarning":false,"name":"BGB-A425","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB-A425","Bgb-a425"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594479","drugType":"Unknown","blackBoxWarning":false,"name":"IRX-2","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytokine-based biologic agent irx-2","Irx 2","Irx-2"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594493","drugType":"Unknown","blackBoxWarning":false,"name":"SARS-COV","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sars-cov"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594526","drugType":"Antibody","blackBoxWarning":false,"name":"TOSATOXUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AR-301","AR301","Ar-301","KBSA-301","KBSA301","Kbsa301","Tosatoxumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594576","drugType":"Unknown","blackBoxWarning":false,"name":"MGC-018","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MGC-018","MGC018","Mgc-018","Mgc018"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL47302","canonicalSmiles":"Cc1nc(C)c(-c2ccnc(N)n2)s1","inchiKey":"CTFDMGIBHFQWKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL47302","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02091"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL475814","canonicalSmiles":"Cc1cc(Nc2ccc3cc4ccccc4cc3c2)n2ncnc2n1","inchiKey":"OXYDLVAOXASTMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL475814","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08006"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL478","canonicalSmiles":"Clc1cccc(N2CCNCC2)c1","inchiKey":"VHFVKMTVMIZMIK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROPHENYLPIPERAZINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-M-Chlorophenyl Piperazine Metabolite","Chlorophenylpiperazine","mCPP"],"crossReferences":{"PubChem":["104171132","11110958","11113750","124879663","144203661","170466760","26751928","50104608"],"Wikipedia":["Meta-Chlorophenylpiperazine"],"drugbank":["DB12110"],"chEBI":["10588"]},"childChemblIds":["CHEMBL1256321","CHEMBL1256029"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL483787","canonicalSmiles":"COc1ccc(CCN([11CH3])CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC","inchiKey":"SGTNSNPWRIOYBX-KTXUZGJCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[11C]-Verapamil","maximumClinicalTrialPhase":0,"parentId":"CHEMBL6966","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[11C]-Verapamil"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL485696","canonicalSmiles":"Cc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(C)n1","inchiKey":"YZMCKZRAOLZXAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFISOMIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sulfaisodimidine","Sulfisomidine","Sulfisomidine sodium","Sulphasomidine"],"crossReferences":{"PubChem":["144205683","170465986"],"Wikipedia":["Sulfisomidine"],"drugbank":["DB13283"],"chEBI":["32166"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL486214","canonicalSmiles":"COC(=O)c1ccc(O)c(OC)c1","inchiKey":"BVWTXUYLKBHMOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL VANILLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Methyl Vanillate","Methylvanillate"],"crossReferences":{"drugbank":["DB08711"],"chEBI":["46477"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489411","canonicalSmiles":"CCC(C)(C)c1ccc(CC(C)CN2C[C@H](C)O[C@H](C)C2)cc1","inchiKey":"MQHLMHIZUIDKOO-AYHJJNSGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOROLFINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loceryl","Loceryl curanail","Omicur"],"synonyms":["Amorolfine","Amorolfine hydrochloride","RO 14-4767/000"],"crossReferences":{"PubChem":["144206074","170466078","50112777"],"Wikipedia":["Amorolfine"],"drugbank":["DB09056"],"chEBI":["599440"]},"childChemblIds":["CHEMBL4303363"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL492514","canonicalSmiles":"COc1ccc(C(=O)N/N=C/c2cc(Br)c(O)c(Br)c2O)cc1","inchiKey":"BMGXNERTVNWBJG-CNHKJKLMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL492514","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06978"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL493","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12","inchiKey":"OZVBMTJYIDMWIL-AYFBDAFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOCRIPTINE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parlodel"],"synonyms":["Bromocriptine","CB-154","SANDOZ 15-754"],"crossReferences":{"DailyMed":["bromocriptine%20mesylate"],"PubChem":["144204458","26751716","26755307","90340796"],"Wikipedia":["Bromocriptine"],"drugbank":["DB01200"],"chEBI":["3181"]},"childChemblIds":["CHEMBL1255752","CHEMBL1200503"],"count":7,"approvedIndications":["EFO_0002508"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0002628","Orphanet_64739","EFO_0000545","EFO_1001757","EFO_0002508","EFO_0000249","EFO_0003847","EFO_0001073","MONDO_0001299","MONDO_0002146","EFO_0003890","EFO_1001485","EFO_0001359","EFO_0007319","EFO_0001360","EFO_0009321","EFO_0004215"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for parkinson's disease and has 6 investigational indications."}
{"id":"CHEMBL493062","canonicalSmiles":"Oc1c(Br)cc(-c2ccccc2)cc1Br","inchiKey":"SKQRVOXIIAXXEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL493062","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["89854824"],"drugbank":["DB08102"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL495727","canonicalSmiles":"O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1","inchiKey":"LOLPPWBBNUVNQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AT-9283","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-9283","AT9283","At 9283","At-9283"],"childChemblIds":["CHEMBL496311"],"count":4,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000096968","ENSG00000097007","ENSG00000178999","ENSG00000105639","ENSG00000122025"],"count":6},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000616","EFO_0001378","EFO_0005952"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL519364","canonicalSmiles":"COc1ccc2c(=O)c(C)c(-c3ccccc3)oc2c1CN(C)C","inchiKey":"ZXFQRFXLFWWKLX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMEFLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimefline"],"crossReferences":{"PubChem":["442471","50125807"],"drugbank":["DB13482"]},"childChemblIds":["CHEMBL1203969"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL549344","canonicalSmiles":"CCc1nc2c(N)nc3ccccc3c2n1CCCCNS(C)(=O)=O","inchiKey":"YZOQZEXYFLXNKA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CPG-52852","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cpg-52852","PF-4878691"],"crossReferences":{"drugbank":["DB12476"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL549385","canonicalSmiles":"O=C1/C(=N\\O)c2c(-c3ccccc3)cccc2N1Cc1cc(F)cc2c1OCOC2","inchiKey":"SZYREAUDQRVVLV-DAFNUICNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL549385","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08015"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL556417","canonicalSmiles":"Cc1cc(C)cc(C(=O)c2c(C(C)C)c(=O)[nH]c(=O)n2CC2CC2)c1","inchiKey":"UCOAKFIVSAVHLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL556417","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14888"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL58343","canonicalSmiles":"NCCCCN=C(N)N","inchiKey":"QYPPJABKJHAVHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AGMATINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Agmatine"],"crossReferences":{"PubChem":["11110769","11113734","124879247","90341553"],"Wikipedia":["Agmatine"],"drugbank":["DB08838"],"chEBI":["17431"]},"childChemblIds":["CHEMBL1256618"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL590799","canonicalSmiles":"CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1","inchiKey":"XASIMHXSUQUHLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Camostat","Camostat mesilate"],"crossReferences":{"PubChem":["174006694","50112779"],"Wikipedia":["Camostat"],"drugbank":["DB13729"]},"childChemblIds":["CHEMBL85164"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL608","canonicalSmiles":"CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1","inchiKey":"FYPMFJGVHOHGLL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROBUCOL","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bisbid","Lorelco","Lurselle","Probucol","Sinlestal"],"synonyms":["DH-581","NSC-652160","NSC-86225","Probucol"],"crossReferences":{"PubChem":["11112687","123183","124882521","144204156","170464772","26748484","50107410","8139943"],"Wikipedia":["Probucol"],"drugbank":["DB01599"],"chEBI":["8427"]},"count":4,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000165029"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0003124","EFO_0000401","MONDO_0002679","EFO_0003774","EFO_0000319","EFO_0004194","EFO_0004265"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL611","canonicalSmiles":"COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC","inchiKey":"VCKUSRYTPJJLNI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERAZOSIN","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hytrin","Terazosin"],"crossReferences":{"DailyMed":["terazosin%20hydrochloride"],"PubChem":["174007477","50085853","855611","90340975"],"Wikipedia":["Terazosin"],"drugbank":["DB01162"],"chEBI":["9445"]},"childChemblIds":["CHEMBL1201091","CHEMBL3989562","CHEMBL1256665"],"count":7,"approvedIndications":["EFO_0000284"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["EFO_0003914","HP_0003124","EFO_0002508","EFO_0001645","HP_0000975","EFO_0000284","EFO_0001360","EFO_0002615","EFO_0000537"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and is indicated for benign prostatic hyperplasia and has 6 investigational indications."}
{"id":"CHEMBL705","canonicalSmiles":"CC1=C(/C=C/C(C)=C\\C=C\\C(C)=C\\C(=O)O)C(C)(C)CCC1","inchiKey":"SHGAZHPCJJPHSC-ZVCIMWCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALITRETINOIN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Panretin","Toctino"],"synonyms":["AGN 192013","AGN-192013","ALRT-1057","ALRT1057","Alitretinoin","BAL-4079","LG-100057","LG100057","LGD-1057","LGD1057","NSC-659772","Panretin","Retinoic acid 9-cis-form"],"crossReferences":{"DailyMed":["alitretinoin"],"PubChem":["144212512","26755228","26755229","26755230"],"Wikipedia":["Alitretinoin"],"drugbank":["DB00523"],"chEBI":["50648"]},"count":7,"approvedIndications":["EFO_0000616","HP_0000964"],"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819","ENSG00000204231","ENSG00000143171","ENSG00000186350"],"count":6},"linkedDiseases":{"rows":["EFO_0003834","EFO_0000616","HP_0000964","MONDO_0007254","EFO_0000676","EFO_0000274","EFO_1000726","EFO_1000706"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for eczema and neoplasm and has 5 investigational indications."}
{"id":"CHEMBL75133","canonicalSmiles":"CC(/C=C/[C@@H]1C[C@]1(C)c1ccc2c(c1)C(C)(C)CCC2(C)C)=C\\C(=O)O","inchiKey":"BOOOLEGQBVUTKC-NVQSDHBMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRX-4204","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-194204","Irx-4204","KB-145960","NRX-194204"],"crossReferences":{"drugbank":["DB11806"]},"count":4,"linkedTargets":{"rows":["ENSG00000204231","ENSG00000143171","ENSG00000186350"],"count":3},"linkedDiseases":{"rows":["EFO_0002508","EFO_0003060","MONDO_0008315","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL8642","canonicalSmiles":"COc1ccc(OC)c(CC(C)N)c1","inchiKey":"LATVFYDIBMDBSY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL8642","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01465"]},"childChemblIds":["CHEMBL557773"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL91829","canonicalSmiles":"CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1","inchiKey":"ZCBUQCWBWNUWSU-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUBOXISTAURIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Arxxant"],"synonyms":["LY-333531","Ly-333531","Ruboxistaurin"],"crossReferences":{"PubChem":["50100106"],"Wikipedia":["Ruboxistaurin"],"drugbank":["DB11829"]},"childChemblIds":["CHEMBL432130"],"count":6,"linkedTargets":{"rows":["ENSG00000166501"],"count":1},"linkedDiseases":{"rows":["EFO_1000783","EFO_0003144","EFO_0001359","EFO_0003770","EFO_0001360","EFO_0009321","EFO_0000400"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL99","canonicalSmiles":"CC(/C=C/C(=O)NO)=C\\[C@@H](C)C(=O)c1ccc(N(C)C)cc1","inchiKey":"RTKIYFITIVXBLE-QEQCGCAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICHOSTATIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-300-I","ANTIBIOTIC A-300","GNF-Pf-1011","Trichostatin","Trichostatin(s)"],"crossReferences":{"PubChem":["26755794","26755795","46371223","96099520"],"Wikipedia":["Trichostatin_A"],"drugbank":["DB04297"],"chEBI":["46024"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
